share_log

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Secora Michael

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Secora Michael

Recursion Pharmaceuticals | 4:持股變動聲明-高管 Secora Michael
美股SEC公告 ·  08/19 19:13
Moomoo AI 已提取核心訊息
Recursion Pharmaceuticals' Chief Financial Officer, Secora Michael, completed a sale of 11,962 shares of the company's Class A Common Stock on August 15, 2024. The transaction was carried out at a price of $6.69 per share, resulting in a total market value of $80,025.78. Following the sale, Secora Michael directly holds 1,353,381 shares in the company. The sale was reported as a means to cover the payment of exercise price or tax liability by delivering or withholding securities.
Recursion Pharmaceuticals' Chief Financial Officer, Secora Michael, completed a sale of 11,962 shares of the company's Class A Common Stock on August 15, 2024. The transaction was carried out at a price of $6.69 per share, resulting in a total market value of $80,025.78. Following the sale, Secora Michael directly holds 1,353,381 shares in the company. The sale was reported as a means to cover the payment of exercise price or tax liability by delivering or withholding securities.
Recursion Pharmaceuticals 致富金融(臨時代碼)的財務總監Secora Michael於2024年8月15日出售了公司11,962股A類普通股,成交價爲6.69美元/股,總市值爲80,025.78美元。交易完成後,Secora Michael直接持有公司1,353,381股。此次出售被報告爲通過交付或保留證券以支付行權價格或稅務負擔。
Recursion Pharmaceuticals 致富金融(臨時代碼)的財務總監Secora Michael於2024年8月15日出售了公司11,962股A類普通股,成交價爲6.69美元/股,總市值爲80,025.78美元。交易完成後,Secora Michael直接持有公司1,353,381股。此次出售被報告爲通過交付或保留證券以支付行權價格或稅務負擔。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息